Attempting to define and refine vasopressin use in septic shock: the VANISH trial

Affiliations

Editorial

Aviral Roy et al. Ann Transl Med. 2016 Dec.

. 2016 Dec;4(24):501.

doi: 10.21037/atm.2016.12.11.

¹ Division of Critical Care, Department of Medicine, Cooper Medical School of Rowan University, Cooper University Health Care, Camden, New Jersey, USA.

No abstract available

Conflict of interest statement

The authors have no conflicts of interest to declare.

Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya HD, Anjum A, Frazier GJ, Santhakumaran S, Ashby D, Brett SJ; VANISH Investigators. Gordon AC, et al. JAMA. 2016 Aug 2;316(5):509-18. doi: 10.1001/jama.2016.10485. JAMA. 2016. PMID: 27483065 Clinical Trial.

1. Murray CJ, Atkinson C, Bhalla K, et al. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 2013;310:591-608. 10.1001/jama.2013.13805 - DOI - PMC - PubMed
1. Lagu T, Rothberg MB, Shieh MS, et al. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med 2012;40:754-61. 10.1097/CCM.0b013e318232db65 - DOI - PubMed
1. Rangel-Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995;273:117-23. 10.1001/jama.1995.03520260039030 - DOI - PubMed
1. Bagshaw SM, Uchino S, Bellomo R, et al. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007;2:431-9. 10.2215/CJN.03681106 - DOI - PubMed
1. Bernardelli AK, Da Silva RC, Corrêa T, et al. Vasoplegia in sepsis depends on the vascular system, vasopressor, and time-point: a comparative evaluation in vessels from rats subjected to the cecal ligation puncture model. Can J Physiol Pharmacol 2016:1-10. [Epub ahead of print]. - PubMed